Macrophage-derived myeloid differentiation protein 2 plays an essential role in ox-LDL-induced inflammation and atherosclerosis

Background: Atherosclerosis is a chronic inflammatory disease. Although Toll-like receptor 4 (TLR4) has been involved in inflammatory atherosclerosis, the exact mechanisms by which oxidized-low-density lipoproteins (ox-LDL) activates TLR4 and elicits inflammatory genesis are not fully known. Myeloid...

Full description

Bibliographic Details
Main Authors: Taiwei Chen, Weijian Huang, Jinfu Qian, Wu Luo, Peiren Shan, Yan Cai, Ke Lin, Gaojun Wu, Guang Liang
Format: Article
Language:English
Published: Elsevier 2020-03-01
Series:EBioMedicine
Online Access:http://www.sciencedirect.com/science/article/pii/S2352396420300815
id doaj-db14d753064e48eca5339d26fee5354b
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Taiwei Chen
Weijian Huang
Jinfu Qian
Wu Luo
Peiren Shan
Yan Cai
Ke Lin
Gaojun Wu
Guang Liang
spellingShingle Taiwei Chen
Weijian Huang
Jinfu Qian
Wu Luo
Peiren Shan
Yan Cai
Ke Lin
Gaojun Wu
Guang Liang
Macrophage-derived myeloid differentiation protein 2 plays an essential role in ox-LDL-induced inflammation and atherosclerosis
EBioMedicine
author_facet Taiwei Chen
Weijian Huang
Jinfu Qian
Wu Luo
Peiren Shan
Yan Cai
Ke Lin
Gaojun Wu
Guang Liang
author_sort Taiwei Chen
title Macrophage-derived myeloid differentiation protein 2 plays an essential role in ox-LDL-induced inflammation and atherosclerosis
title_short Macrophage-derived myeloid differentiation protein 2 plays an essential role in ox-LDL-induced inflammation and atherosclerosis
title_full Macrophage-derived myeloid differentiation protein 2 plays an essential role in ox-LDL-induced inflammation and atherosclerosis
title_fullStr Macrophage-derived myeloid differentiation protein 2 plays an essential role in ox-LDL-induced inflammation and atherosclerosis
title_full_unstemmed Macrophage-derived myeloid differentiation protein 2 plays an essential role in ox-LDL-induced inflammation and atherosclerosis
title_sort macrophage-derived myeloid differentiation protein 2 plays an essential role in ox-ldl-induced inflammation and atherosclerosis
publisher Elsevier
series EBioMedicine
issn 2352-3964
publishDate 2020-03-01
description Background: Atherosclerosis is a chronic inflammatory disease. Although Toll-like receptor 4 (TLR4) has been involved in inflammatory atherosclerosis, the exact mechanisms by which oxidized-low-density lipoproteins (ox-LDL) activates TLR4 and elicits inflammatory genesis are not fully known. Myeloid differentiation factor 2 (MD2) is an extracellular molecule indispensable for lipopolysaccharide recognition of TLR4. Method: Apoe−/−Md2−/− mice and pharmacological inhibitor of MD2 were used in this study. We also reconstituted Apoe−/− mice with either Apoe−/− or Apoe−/−Md2−/− marrow-derived cells. Mechanistic studies were performed in primary macrophages, HEK-293T cells, and cell-free system. Finding: MD2 levels are elevated in atherosclerotic lesion macrophages, and MD2 deficiency or pharmacological inhibition in mice reduces the inflammation and stunts the development of atherosclerotic lesions in Apoe−/− mice fed with high-fat diet. Transfer of marrow-derived cells from Apoe-Md2 double knockout mice to Apoe knockout mice confirmed the critical role of bone marrow-derived MD2 in inflammatory factor induction and atherosclerosis development. Mechanistically, we show that MD2 does not alter ox-LDL uptake by macrophages but is required for TLR4 activation and inflammation via directly binding to ox-LDL, which triggers MD2/TLR4 complex formation and TLR4-MyD88-NFκB pro-inflammatory cascade. Interpretation: We provide a mechanistic basis of ox-LDL-induced macrophage inflammation, illustrate the role of macrophage-derived MD2 in atherosclerosis, and support the therapeutic potential of MD2 targeting in atherosclerosis-driven cardiovascular diseases. Funding: This work was supported by the National Key Research Project of China (2017YFA0506000), National Natural Science Foundation of China (21961142009, 81930108, 81670244, and 81700402), and Natural Science Foundation of Zhejiang Province (LY19H020004). Keywords: Myeloid differentiation-2, Oxidized-LDL, Toll-like receptor 4, Atherosclerosis, Inflammation, Macrophages
url http://www.sciencedirect.com/science/article/pii/S2352396420300815
work_keys_str_mv AT taiweichen macrophagederivedmyeloiddifferentiationprotein2playsanessentialroleinoxldlinducedinflammationandatherosclerosis
AT weijianhuang macrophagederivedmyeloiddifferentiationprotein2playsanessentialroleinoxldlinducedinflammationandatherosclerosis
AT jinfuqian macrophagederivedmyeloiddifferentiationprotein2playsanessentialroleinoxldlinducedinflammationandatherosclerosis
AT wuluo macrophagederivedmyeloiddifferentiationprotein2playsanessentialroleinoxldlinducedinflammationandatherosclerosis
AT peirenshan macrophagederivedmyeloiddifferentiationprotein2playsanessentialroleinoxldlinducedinflammationandatherosclerosis
AT yancai macrophagederivedmyeloiddifferentiationprotein2playsanessentialroleinoxldlinducedinflammationandatherosclerosis
AT kelin macrophagederivedmyeloiddifferentiationprotein2playsanessentialroleinoxldlinducedinflammationandatherosclerosis
AT gaojunwu macrophagederivedmyeloiddifferentiationprotein2playsanessentialroleinoxldlinducedinflammationandatherosclerosis
AT guangliang macrophagederivedmyeloiddifferentiationprotein2playsanessentialroleinoxldlinducedinflammationandatherosclerosis
_version_ 1724706976379699200
spelling doaj-db14d753064e48eca5339d26fee5354b2020-11-25T02:58:20ZengElsevierEBioMedicine2352-39642020-03-0153Macrophage-derived myeloid differentiation protein 2 plays an essential role in ox-LDL-induced inflammation and atherosclerosisTaiwei Chen0Weijian Huang1Jinfu Qian2Wu Luo3Peiren Shan4Yan Cai5Ke Lin6Gaojun Wu7Guang Liang8Department of Cardiology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China; Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, ChinaDepartment of Cardiology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, ChinaDepartment of Cardiology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China; Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, ChinaChemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, ChinaDepartment of Cardiology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, ChinaThe Affiliated Cangnan Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, ChinaDepartment of Cardiology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China; Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, ChinaDepartment of Cardiology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China; Corresponding author: Department of Cardiology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.Department of Cardiology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China; Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, China; Zhuji Biomedicine Institute, School of Pharmaceutical Sciences, Wenzhou Medical University, Zhuji, Zhejiang, China; Corresponding author at: Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, China.Background: Atherosclerosis is a chronic inflammatory disease. Although Toll-like receptor 4 (TLR4) has been involved in inflammatory atherosclerosis, the exact mechanisms by which oxidized-low-density lipoproteins (ox-LDL) activates TLR4 and elicits inflammatory genesis are not fully known. Myeloid differentiation factor 2 (MD2) is an extracellular molecule indispensable for lipopolysaccharide recognition of TLR4. Method: Apoe−/−Md2−/− mice and pharmacological inhibitor of MD2 were used in this study. We also reconstituted Apoe−/− mice with either Apoe−/− or Apoe−/−Md2−/− marrow-derived cells. Mechanistic studies were performed in primary macrophages, HEK-293T cells, and cell-free system. Finding: MD2 levels are elevated in atherosclerotic lesion macrophages, and MD2 deficiency or pharmacological inhibition in mice reduces the inflammation and stunts the development of atherosclerotic lesions in Apoe−/− mice fed with high-fat diet. Transfer of marrow-derived cells from Apoe-Md2 double knockout mice to Apoe knockout mice confirmed the critical role of bone marrow-derived MD2 in inflammatory factor induction and atherosclerosis development. Mechanistically, we show that MD2 does not alter ox-LDL uptake by macrophages but is required for TLR4 activation and inflammation via directly binding to ox-LDL, which triggers MD2/TLR4 complex formation and TLR4-MyD88-NFκB pro-inflammatory cascade. Interpretation: We provide a mechanistic basis of ox-LDL-induced macrophage inflammation, illustrate the role of macrophage-derived MD2 in atherosclerosis, and support the therapeutic potential of MD2 targeting in atherosclerosis-driven cardiovascular diseases. Funding: This work was supported by the National Key Research Project of China (2017YFA0506000), National Natural Science Foundation of China (21961142009, 81930108, 81670244, and 81700402), and Natural Science Foundation of Zhejiang Province (LY19H020004). Keywords: Myeloid differentiation-2, Oxidized-LDL, Toll-like receptor 4, Atherosclerosis, Inflammation, Macrophageshttp://www.sciencedirect.com/science/article/pii/S2352396420300815